Your browser doesn't support javascript.
loading
Gamma-Delta T-Cell Lymphoma Following Allogeneic Stem Cell Transplant for Primary Myelofibrosis.
Hoard, Robert; Shahin, George; Andreca, Florin D; Osswald, Michael.
Afiliação
  • Hoard R; Internal Medicine, San Antonio Uniformed Services Health Education Consortium (SAUSHEC), San Antonio, USA.
  • Shahin G; Internal Medicine: Hematology / Oncology, San Antonio Uniformed Services Health Education Consortium (SAUSHEC), San Antonio, USA.
  • Andreca FD; Hematology / Oncology, Wright-Patterson Air Force Base (WPAFB), Dayton, USA.
  • Osswald M; Hematology / Oncology, Brooke Army Medical Center, San Antonio, USA.
Cureus ; 12(9): e10301, 2020 Sep 07.
Article em En | MEDLINE | ID: mdl-33052264
Primary myelofibrosis (PMF) is a disease that affects the bone marrow. It presents with cytopenias, hepatospleomegaly accompanied with extramedullary hematopoiesis, and often with constitutional symptoms. Cytotoxic gamma-delta T-cells are considered a distinct hepatosplenic lymohoma. This is a case presentation of a 43-year-old male with an initial diagnosis of PMF who underwent allogeneic stem cell transplantation complicated by primary graft failure. He subsequently underwent a partial splenic embolization; however, he quickly developed a fulminant hepatosplenic gamma-delta T-cell lymphoma which led to his death that was diagnosed posthumously. PMF has been known to transform into an acute myeloid leukemia, but there has been no established link with gamma-delta T-cell lymphoma.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article